Famotidine
Product Images NDC 68151-0184

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 68151-0184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 0184)

Label Image (68151 0184)
Famotidine 20 mg tablet label showing dosage strength and form. The label includes manufacturer information listed as PLIVA, a lot number (9836113), expiration date (11/14), a barcode, and text indicating prescription use (RX ONLY). The product is associated with Carilion Materials Management.*
FDA Label Image

Container40mg (Container40mg)

Container40mg (Container40mg)
Famotidine 40 mg tablets label from Carilion Materials Management. The image shows a white and red label with blue and black text. It states 30 tablets, with directions for storage at controlled room temperature and warnings to keep out of reach of children. The label also includes dosing information and the manufacturer Dr. Reddy's Laboratories Limited, India.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of famotidine, an active pharmaceutical ingredient. The diagram shows the molecular arrangement including a thiazole ring, guanidine group, and a sulfamoyl functional group attached through a propyl chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.